Guyasuta Investment Advisors Inc. purchased a new stake in shares of Welltower Inc. (NYSE:WELL - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 2,074 shares of the real estate investment trust's stock, valued at approximately $261,000.
Several other large investors have also made changes to their positions in the company. Wellington Management Group LLP lifted its stake in shares of Welltower by 10.6% during the third quarter. Wellington Management Group LLP now owns 18,685,844 shares of the real estate investment trust's stock valued at $2,392,349,000 after acquiring an additional 1,797,330 shares during the period. FMR LLC increased its holdings in Welltower by 38.1% in the third quarter. FMR LLC now owns 14,428,564 shares of the real estate investment trust's stock valued at $1,847,289,000 after purchasing an additional 3,977,845 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in Welltower by 638.0% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 6,920,426 shares of the real estate investment trust's stock valued at $886,022,000 after purchasing an additional 5,982,711 shares during the last quarter. Charles Schwab Investment Management Inc. increased its holdings in Welltower by 0.8% in the third quarter. Charles Schwab Investment Management Inc. now owns 6,066,213 shares of the real estate investment trust's stock valued at $776,657,000 after purchasing an additional 46,332 shares during the last quarter. Finally, Sumitomo Mitsui Trust Group Inc. increased its holdings in Welltower by 6.6% in the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,106,666 shares of the real estate investment trust's stock valued at $391,533,000 after purchasing an additional 192,303 shares during the last quarter. Institutional investors and hedge funds own 94.80% of the company's stock.
Analyst Ratings Changes
A number of research firms recently commented on WELL. Raymond James upped their price objective on Welltower from $145.00 to $155.00 and gave the company a "strong-buy" rating in a report on Monday, December 16th. Scotiabank upped their price objective on Welltower from $142.00 to $144.00 and gave the company a "sector outperform" rating in a report on Monday, January 27th. Wedbush upgraded Welltower from a "neutral" rating to an "outperform" rating and upped their price objective for the company from $145.00 to $167.00 in a report on Friday, February 14th. Bank of America upped their price objective on Welltower from $221.00 to $242.00 and gave the company a "buy" rating in a report on Tuesday. Finally, Jefferies Financial Group upgraded Welltower from a "hold" rating to a "buy" rating and increased their price target for the stock from $132.00 to $147.00 in a report on Thursday, January 2nd. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, nine have assigned a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $140.19.
Get Our Latest Analysis on Welltower
Welltower Stock Down 0.7 %
NYSE WELL traded down $1.09 during trading hours on Wednesday, hitting $149.71. 2,314,176 shares of the company traded hands, compared to its average volume of 2,596,873. The business's 50-day moving average is $132.58 and its 200-day moving average is $129.60. Welltower Inc. has a twelve month low of $87.87 and a twelve month high of $152.81. The company has a debt-to-equity ratio of 0.48, a quick ratio of 4.22 and a current ratio of 4.22. The stock has a market capitalization of $96.01 billion, a price-to-earnings ratio of 95.97, a P/E/G ratio of 2.94 and a beta of 1.23.
Welltower (NYSE:WELL - Get Free Report) last released its quarterly earnings data on Tuesday, February 11th. The real estate investment trust reported $1.13 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.40 by $0.73. Welltower had a return on equity of 3.15% and a net margin of 11.91%. Sell-side analysts anticipate that Welltower Inc. will post 4.87 earnings per share for the current year.
Welltower Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, March 6th. Stockholders of record on Tuesday, February 25th will be given a $0.67 dividend. The ex-dividend date is Tuesday, February 25th. This represents a $2.68 dividend on an annualized basis and a dividend yield of 1.79%. Welltower's payout ratio is 171.79%.
About Welltower
(
Free Report)
Welltower Inc NYSE: WELL, a real estate investment trust ("REIT") and S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. Welltower invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people's wellness and overall health care experience.
Recommended Stories

Before you consider Welltower, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Welltower wasn't on the list.
While Welltower currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.